» Articles » PMID: 31028447

Prediction of Response After Chemoradiation for Esophageal Cancer Using a Combination of Dosimetry and CT Radiomics

Overview
Journal Eur Radiol
Specialty Radiology
Date 2019 Apr 28
PMID 31028447
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the treatment response prediction feasibility and accuracy of an integrated model combining computed tomography (CT) radiomic features and dosimetric parameters for patients with esophageal cancer (EC) who underwent concurrent chemoradiation (CRT) using machine learning.

Methods: The radiomic features and dosimetric parameters of 94 EC patients were extracted and modeled using Support Vector Classification (SVM) and Extreme Gradient Boosting algorithm (XGBoost). The 94-sample dataset was randomly divided into a 70-sample training subset and a 24-sample independent test set while keeping the class proportions intact via stratification. A receiver operating characteristic (ROC) curve was used to assess the performance of models using radiomic features alone and using combined radiomic features and dosimetric parameters.

Results: A total of 42 radiomic features and 18 dosimetric parameters plus the patients' characteristic parameters were extracted for these 94 cases (58 responders and 36 non-responders). XGBoost plus principal component analysis (PCA) achieved an accuracy and area under the curve of 0.708 and 0.541, respectively, for models with radiomic features combined with dosimetric parameters, and 0.689 and 0.479, respectively, for radiomic features alone. Image features of GlobalMean X.333.1, Coarseness, Skewness, and GlobalStd contributed most to the model. The dosimetric parameters of gross tumor volume (GTV) homogeneity index (HI), Cord Dmax, Prescription dose, Heart-Dmean, and Heart-V50 also had a strong contribution to the model.

Conclusions: The model with radiomic features combined with dosimetric parameters is promising and outperforms that with radiomic features alone in predicting the treatment response of patients with EC who underwent CRT.

Key Points: • The model with radiomic features combined with dosimetric parameters is promising in predicting the treatment response of patients with EC who underwent CRT. • The model with radiomic features combined with dosimetric parameters (prediction accuracy of 0.708 and AUC of 0.689) outperforms that with radiomic features alone (best prediction accuracy of 0.625 and AUC of 0.412). • The image features of GlobalMean X.333.1, Coarseness, Skewness, and GlobalStd contributed most to the treatment response prediction model. The dosimetric parameters of GTV HI, Cord Dmax, Prescription dose, Heart-Dmean, and Heart-V50 also had a strong contribution to the model.

Citing Articles

Radiomics model building from multiparametric MRI to predict Ki-67 expression in patients with primary central nervous system lymphomas: a multicenter study.

Shen Y, Wu S, Wu Y, Cui C, Li H, Yang S BMC Med Imaging. 2025; 25(1):54.

PMID: 39962371 PMC: 11834475. DOI: 10.1186/s12880-025-01585-5.


Radiomics model based on computed tomography images for prediction of radiation-induced optic neuropathy following radiotherapy of brain and head and neck tumors.

Nafchi E, Fadavi P, Amiri S, Cheraghi S, Garousi M, Nabavi M Heliyon. 2025; 11(1):e41409.

PMID: 39839516 PMC: 11750450. DOI: 10.1016/j.heliyon.2024.e41409.


A predictive model based on radiomics, clinical features, and pathologic indicators for disease-free survival after liver transplantation for hepatocellular carcinoma: a 7-year retrospective study.

Xie H, Shi B, Fan J, Liu S, Ma Q, Dai J J Gastrointest Oncol. 2024; 15(5):2187-2200.

PMID: 39554565 PMC: 11565123. DOI: 10.21037/jgo-24-347.


Using high-repeatable radiomic features improves the cross-institutional generalization of prognostic model in esophageal squamous cell cancer receiving definitive chemoradiotherapy.

Gong J, Wang Q, Li J, Yang Z, Zhang J, Teng X Insights Imaging. 2024; 15(1):239.

PMID: 39373828 PMC: 11458848. DOI: 10.1186/s13244-024-01816-3.


A machine learning radiomics based on enhanced computed tomography to predict neoadjuvant immunotherapy for resectable esophageal squamous cell carcinoma.

Wang J, Tang L, Zhong X, Wang Y, Feng Y, Zhang Y Front Immunol. 2024; 15:1405146.

PMID: 38947338 PMC: 11211602. DOI: 10.3389/fimmu.2024.1405146.


References
1.
Zhang L, Fried D, Fave X, Hunter L, Yang J, Court L . IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med Phys. 2015; 42(3):1341-53. PMC: 5148126. DOI: 10.1118/1.4908210. View

2.
Chen Y, Liu A, Han C, Tsai P, Schultheiss T, Pezner R . Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim. 2007; 32(3):166-71. DOI: 10.1016/j.meddos.2006.12.003. View

3.
Muijs C, Beukema J, Pruim J, Mul V, Groen H, Plukker J . A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol. 2010; 97(2):165-71. DOI: 10.1016/j.radonc.2010.04.024. View

4.
Chao Y, Chan S, Liu Y, Chen H, Wan Y, Chang H . Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Ann Surg. 2009; 249(3):392-6. DOI: 10.1097/SLA.0b013e3181949e9f. View

5.
Hammoud Z, Kesler K, Ferguson M, Battafarrano R, Bhogaraju A, Hanna N . Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus. 2006; 19(2):69-72. DOI: 10.1111/j.1442-2050.2006.00542.x. View